UFC Middleweight Champion Israel Adesanya Denies Accusations

Israel Adesanya has heard recent accusations and he gets a chuckle out of them.

Adesanya competed in the main event of UFC 253 on September 26. He put his UFC Middleweight Title on the line against Paulo Costa. The action was held inside the Flash Forum on Yas Island in Abu Dhabi. Adesanya turned in a dominant performance, stopping Costa in the second round via TKO.

Some questioned Adesanya’s right pectoral muscle as it appeared to be far different from his left. Steroid accusations have even been hurled. Adesanya says he underwent a blood test and two MRI scans to diagnose the swollen pectoral muscle.

Speaking to ESPN’s Ariel Helwani, “The Last Stylebender” said he may just keep people out of the loop on the situation but he denies using performance-enhancing drugs (h/t MMAFighting.com).

“I’ll wait for the results. I might keep you posted, or I might people speculate. It’s kind of fun to watch people cry about it. I don’t know what this is, but you know what? With a performance like that, I would think I was on steroids, too. They need something. ‘It couldn’t just be him. It couldn’t be him.’ It must be something.’ So for me, it’s just fun and games.

“I’m not one of those people who needs a crutch, that when that gets taken away, they feel weak, they feel inadequate,” said Adesanya, who’s been tested 32 times by the U.S. Anti-Doping Agency without issue. “You see when USADA came through, a lot of people fell off. A lot of bodies changed, and a lot of people didn’t feel good enough without their little magic supplements. But yeah – not me. Skills, bro. Skills pay the bills.”

With the win over Costa, Adesanya improved his pro MMA record to 20-0. Along the way, he has nabbed 15 of those wins via knockout or TKO.

You might also like
By using our site you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Service. X

SIGN UP NOW!

Breaking News And Highlights Around Boxing, MMA, Kickboxing, Martial Arts and more!

By signing up, you agree to comply with our Terms of Service and Privacy Policy.